Evidence map›Paper›PMID 28077237›Full record

ReviewCellular immunology2017

Interplay of extracellular matrix and leukocytes in lung inflammation.

Thomas N Wight, Charles W Frevert, Jason S Debley, Stephen R Reeves, William C Parks, Steven F Ziegler

Open access · greenAbstract readReview
In one paragraph

Review in Cellular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 106 citations in OpenAlex.

  1. Oral hymecromone decreases hyaluronan in human study participants.The Journal of clinical investigation · 2022
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. V3: an enigmatic isoform of the proteoglycan versican.American journal of physiology. Cell physiology · 2023
    Review
  16. Article
  17. Article
  18. Development of Adaptive Immunity and Its Role in Lung Remodeling.Advances in experimental medicine and biology · 2023
    Article
  19. Defining the versican interactome in lung health and disease.American journal of physiology. Cell physiology · 2022
    Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Thomas N WightMatrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA. Electronic address: twight@benaroyaresearch.org.
Charles W FrevertDepartment of Comparative Medicine, University of Washington, Seattle, WA, USA.
Jason S DebleyCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, and Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Stephen R ReevesCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, and Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
William C ParksDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Steven F ZieglerImmunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
Benaroya Research InstituteUniversity of Washington · USCedars-Sinai Medical Center · USSeattle Children's Hospital · US

Funding

Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and ImmP01HL098067 · NHLBI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI FREVERT, CHARLES WAYNE · 2010 to 2014
$13.5M
Regulation of the Innate Immune Response by the Epithelium in AsthmaU19AI125378 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J · 2016 to 2020
$9.2M
TSLP and the Pathophysiology of AsthmaR01AI068731 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI ZIEGLER, STEVEN F · 2006 to 2016
$4.5M
MMP10 Control of Macrophage Activation in COPDR01HL089455 · NHLBI · UNIVERSITY OF WASHINGTON · PI PARKS, WILLIAM C · 2011 to 2014
$1.7M
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic ChildrenR01HL128361 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2016 to 2018
$1.4M
Role of MMP10 in Macrophage ActivationR56HL128995 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI PARKS, WILLIAM C · 2015 to 2015
$540k
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic ChildrenR56HL128361 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2015 to 2015
$483k
NHLBI NIH HHS P01 HL098067NHLBI NIH HHS R01 HL089455NHLBI NIH HHS R01 HL128361NHLBI NIH HHS R56 HL128361NHLBI NIH HHS R56 HL128995NIAID NIH HHS R01 AI068731NIAID NIH HHS U19 AI125378
6 · The paper itself

Abstract

During inflammation, leukocytes influx into lung compartments and interact with extracellular matrix (ECM). Two ECM components, versican and hyaluronan, increase in a range of lung diseases. The interaction of leukocytes with these ECM components controls leukocyte retention and accumulation, proliferation, migration, differentiation, and activation as part of the inflammatory phase of lung disease. In addition, bronchial epithelial cells from asthmatic children co-cultured with human lung fibroblasts generate an ECM that is adherent for monocytes/macrophages. Macrophages are present in both early and late lung inflammation. Matrix metalloproteinase 10 (MMP10) is induced in alveolar macrophages with injury and infection and modulates macrophage phenotype and their ability to degrade collagenous ECM components. Collectively, studies outlined in this review highlight the importance of specific ECM components in the regulation of inflammatory events in lung disease. The widespread involvement of these ECM components in the pathogenesis of lung inflammation make them attractive candidates for therapeutic intervention.

Indexed as

AnimalsCell DifferentiationCell MovementExtracellular MatrixHumansHyaluronic AcidLeukocytesMacrophages, AlveolarMatrix Metalloproteinase 10Molecular Targeted TherapyPneumoniaVersicansHyaluronic AcidMatrix Metalloproteinase 10VersicansAsthmaExtracellular matrixFibrosisHyaluronanImmunityInflammationMacrophageMatrix metalloproteinase 10Versican

Identifiers

PMID28077237
PMCPMC5290208
OpenAlexW2565849713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.